138 related articles for article (PubMed ID: 33517655)
21. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
22. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models.
Yue J; Liu S; Wang R; Hu X; Xie Z; Huang Y; Jing X
Mol Pharm; 2012 Jul; 9(7):1919-31. PubMed ID: 22616905
[TBL] [Abstract][Full Text] [Related]
23. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
24. Relations between the intracellular pathways of the receptors for transferrin, asialoglycoprotein, and mannose 6-phosphate in human hepatoma cells.
Stoorvogel W; Geuze HJ; Griffith JM; Schwartz AL; Strous GJ
J Cell Biol; 1989 Jun; 108(6):2137-48. PubMed ID: 2544602
[TBL] [Abstract][Full Text] [Related]
25. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
26. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
27. In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.
Anabousi S; Bakowsky U; Schneider M; Huwer H; Lehr CM; Ehrhardt C
Eur J Pharm Sci; 2006 Dec; 29(5):367-74. PubMed ID: 16952451
[TBL] [Abstract][Full Text] [Related]
28. Y-shaped ligand-driven gold nanoparticles for highly efficient tumoral uptake and photothermal ablation.
Lee UY; Youn YS; Park J; Lee ES
ACS Nano; 2014 Dec; 8(12):12858-65. PubMed ID: 25453897
[TBL] [Abstract][Full Text] [Related]
29. The pathways of endocytosed transferrin and secretory protein are connected in the trans-Golgi reticulum.
Stoorvogel W; Geuze HJ; Griffith JM; Strous GJ
J Cell Biol; 1988 Jun; 106(6):1821-9. PubMed ID: 3260238
[TBL] [Abstract][Full Text] [Related]
30. Atomic force microscopy-based cell nanostructure for ligand-conjugated quantum dot endocytosis.
Pan YL; Cai JY; Qin L; Wang H
Acta Biochim Biophys Sin (Shanghai); 2006 Sep; 38(9):646-52. PubMed ID: 16953304
[TBL] [Abstract][Full Text] [Related]
31. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
32. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
Tortorella S; Karagiannis TC
Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
[TBL] [Abstract][Full Text] [Related]
33. The influence of coupling transferrin to liposomes or minibeads on its uptake and fate in leukemic L2C cells.
Vidal M; Sainte-Marie J; Philippot JR; Bienvenue A
FEBS Lett; 1987 May; 216(1):159-63. PubMed ID: 3582664
[TBL] [Abstract][Full Text] [Related]
34. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.
Wiley DT; Webster P; Gale A; Davis ME
Proc Natl Acad Sci U S A; 2013 May; 110(21):8662-7. PubMed ID: 23650374
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments.
Davies PS; Zhang AS; Anderson EL; Roy CN; Lampson MA; McGraw TE; Enns CA
Biochem J; 2003 Jul; 373(Pt 1):145-53. PubMed ID: 12667138
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing the Cellular Transport of Folic Acid Conjugated Nano-Drugs among Different Cell Lines by Using Force Tracing Technique.
Shan M; Wang H; Li S; Zhang X; Yang G; Shan Y
Mol Pharm; 2023 Jun; 20(6):3234-3240. PubMed ID: 37083400
[TBL] [Abstract][Full Text] [Related]
37. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.
Wang Z; Zhao Y; Jiang Y; Lv W; Wu L; Wang B; Lv L; Xu Q; Xin H
Sci Rep; 2015 Jul; 5():12651. PubMed ID: 26219474
[TBL] [Abstract][Full Text] [Related]
38. Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles.
Johnsen KB; Bak M; Kempen PJ; Melander F; Burkhart A; Thomsen MS; Nielsen MS; Moos T; Andresen TL
Theranostics; 2018; 8(12):3416-3436. PubMed ID: 29930740
[No Abstract] [Full Text] [Related]
39. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
40. Receptor-mediated endocytosis and intracellular trafficking of lipoproteins and transferrin in insect cells.
Van Hoof D; Rodenburg KW; Van der Horst DJ
Insect Biochem Mol Biol; 2005 Feb; 35(2):117-28. PubMed ID: 15681222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
